Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
Clinical trial NCT04221945 · COMPLETED
Trial details
- NCT number
- NCT04221945
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2025-01-07
- Enrollment
- 1060
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.